JP2025500308A5 - - Google Patents

Info

Publication number
JP2025500308A5
JP2025500308A5 JP2024537016A JP2024537016A JP2025500308A5 JP 2025500308 A5 JP2025500308 A5 JP 2025500308A5 JP 2024537016 A JP2024537016 A JP 2024537016A JP 2024537016 A JP2024537016 A JP 2024537016A JP 2025500308 A5 JP2025500308 A5 JP 2025500308A5
Authority
JP
Japan
Prior art keywords
substituted
alkyl
cycloalkyl
pharmaceutically acceptable
ocf3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024537016A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025500308A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/053798 external-priority patent/WO2023122267A2/en
Publication of JP2025500308A publication Critical patent/JP2025500308A/ja
Publication of JP2025500308A5 publication Critical patent/JP2025500308A5/ja
Pending legal-status Critical Current

Links

JP2024537016A 2021-12-22 2022-12-22 哺乳類slc6a19機能の小分子阻害剤 Pending JP2025500308A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163292818P 2021-12-22 2021-12-22
US63/292,818 2021-12-22
PCT/US2022/053798 WO2023122267A2 (en) 2021-12-22 2022-12-22 Small molecule inhibitors of mammalian slc6a19 function

Publications (2)

Publication Number Publication Date
JP2025500308A JP2025500308A (ja) 2025-01-09
JP2025500308A5 true JP2025500308A5 (https=) 2026-01-06

Family

ID=86903643

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024537016A Pending JP2025500308A (ja) 2021-12-22 2022-12-22 哺乳類slc6a19機能の小分子阻害剤

Country Status (5)

Country Link
US (1) US20250084054A1 (https=)
EP (1) EP4452943A4 (https=)
JP (1) JP2025500308A (https=)
CN (1) CN118829628A (https=)
WO (1) WO2023122267A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4304586A4 (en) 2021-03-10 2025-04-02 Jnana Therapeutics Inc. SMALL MOLECULE INHIBITORS OF MAMMALIAN SLC6A19 FUNCTION
CN119522265A (zh) * 2022-12-12 2025-02-25 雪佛龙美国公司 用于进料至炼油厂单元的废塑料与石油进料的稳定共混物的方法及其制备方法
WO2025196623A1 (en) 2024-03-21 2025-09-25 Pfizer Inc. Indole analogs
TW202547506A (zh) * 2024-04-10 2025-12-16 大陸商長春金賽藥業有限責任公司 Slc6a19抑制劑化合物、藥物組合物及其製備方法和用途
WO2025217521A1 (en) * 2024-04-12 2025-10-16 Jnana Therapeutics Inc. Treating chronic kidney disease with a combination of a slc6a19 inhibitor and a glp-1 agonist
US20250346567A1 (en) 2024-05-13 2025-11-13 Pfizer Inc. Substituted pyridine and phenyl compounds
WO2026038155A1 (en) 2024-08-16 2026-02-19 Pfizer Inc. Substituted pyridine compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4304586A4 (en) * 2021-03-10 2025-04-02 Jnana Therapeutics Inc. SMALL MOLECULE INHIBITORS OF MAMMALIAN SLC6A19 FUNCTION

Similar Documents

Publication Publication Date Title
JP2025500308A5 (https=)
JP2024509818A5 (https=)
JP5937968B2 (ja) Mcl‐1を調節する小分子、並びに細胞死、細胞分裂、細胞分化を調節する方法、及び疾患を治療する方法。
JP2023528713A5 (https=)
ES2536442T3 (es) Derivados novedosos de triazolil piperazina y triazolil piperidina como moduladores de la gamma secretasa
ES2546063T3 (es) Agentes de enlace a amiloides
JP2010528089A5 (https=)
JP2019530715A5 (https=)
JP2009530306A5 (https=)
JP6387361B2 (ja) ピリジン−4−イル誘導体
JP2007504160A5 (https=)
JP2022519131A5 (https=)
JP2022533069A5 (https=)
JP2011519854A5 (https=)
CN1124960A (zh) 作为5-ht/a和/或5-ht2配体的吲哚衍生物
JP2009527501A5 (https=)
JP2007502264A5 (https=)
KR20120055571A (ko) 종양성 또는 자가면역 질환 치료용 전구약물로서의 푸라자노벤즈이미다졸
JP2023516187A5 (https=)
JP2021512913A5 (https=)
WO2019201297A1 (zh) 作为rho激酶抑制剂的苯并吡唑类化合物
CN111285829A (zh) 一类PPARγ/δ双重激动剂、其制备方法及其作为药物的用途
CN118829628A (zh) 哺乳动物slc6a19功能的小分子抑制剂
JP2011527330A (ja) スニチニブリンゴ酸塩の結晶形の調製方法
CN120076806A (zh) 使用slc6a19功能的螺取代的和其他哌啶抑制剂治疗pku